5 Key Takeaways
-
1
Dr. Kevin Chan led a session at the 2025 GSLS focusing on the complexities of myopia progression and treatment strategies.
-
2
Ortho-k is effective in slowing axial length progression in young patients, but responses vary, necessitating personalized treatment approaches.
-
3
The axial length-to-corneal radius ratio is a better predictor of myopia progression than axial length alone.
-
4
Emerging treatment combinations, like low-dose atropine with ortho-k, show promise for patients with rapid myopia progression.
-
5
Individualized patient care is crucial in myopia management, integrating clinical analysis with behavioral recommendations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.